<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000747093">
  <TermName>ado-trastuzumab emtansine</TermName>
  <TermPronunciation>(A-doh-tras-TOO-zoo-mab em-TAN-seen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A drug used to treat certain patients with HER2-positive breast cancer that has already been treated with trastuzumab and a type of anticancer drug called a taxane. It is also being studied in the treatment of other types of cancer.   Ado-trastuzumab emtansine contains a monoclonal antibody called trastuzumab that binds to a protein called HER2, which is found on some breast cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells. Ado-trastuzumab emtansine is a type of antibody-drug conjugate. Also called Kadcyla and T-DM1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000749859" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ado-trastuzumab emtansine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000749858" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;ado-trastuzumab emtansina&quot;" language="es" id="_4"/>
  <SpanishTermName>ado-trastuzumab emtansina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Medicamento que se usa para el tratamiento de ciertos pacientes con cáncer de mama positivo para HER2 que se trataron antes con trastuzumab y un tipo de medicamento contra el cáncer perteneciente al grupo de los taxanos. También está en estudio para el tratamiento de otros tipos de cáncer. El ado-trastuzumab emtansina contiene un anticuerpo monoclonal que se llama trastuzumab que se une a una proteína llamada HER2, que se encuentra en algunas células cancerosas de mama. Además, contiene DM1, un fármaco contra el cáncer que quizás ayude a destruir células cancerosas. El ado-trastuzumab emtansina es un tipo de conjugado anticuerpo-fármaco. También se llama Kadcyla y T-DM1.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2013-03-13</DateFirstPublished>
  <DateLastModified>2021-06-02</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000746946" url="/about-cancer/treatment/drugs/ado-trastuzumab-emtansine">Ado-Trastuzumab Emtansine</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
